Logout successfull!

A Glimpse into the Future of Orthopedics:
Insights, Trends and News from the World of Hip Replacement and Beyond

Metal Neurotoxicity: Implications for the patients

Martínez-Hernández et al. reviewed the role of microglia in metal neurotoxicity and their role in the development of neurodegenerative diseases.

Read more

THA in the under twenties: Ceramic-on-Ceramic as the treatment of choice

Clinical outcomes of total hip arthroplasty (THA) in teenage patients are still controversially discussed and there are still concerns related to the survival of implanted prostheses.

Read more

Ceramic hip bearings continuously gaining ground in US healthcare

Bearing material composition has proven to be crucial in determining the longevity and functionality of hip implants.

Read more

Continued trend in ceramic use in Germany

Ceramic Insights of EPRD - ENDOPROTHESENREGISTER DEUTSCHLAND (German Arthroplasty Registry) 2023.

Read more

Cobalt toxicity after hip arthroplasty

Cobalt chromium alloy has been recognized by NIS as a toxic substance, and evidence has demonstrated that high blood levels of cobalt ions can lead to systemic effects in hip patients.

Read more

Does vitamin D deficiency / insufficiency lead to worse outcomes in Total Joint Arthroplasty?

According to recent data, there is a prevalence of vitamin D deficiency in the general US population of 41.6%.

Read more

Italian Regional Registry Study – Modular head-neck adapter system & ceramic heads in revision hip arthroplasty

The study published by Rizzoli’s group investigated the survival rates and reasons for re-revisions, with a focus on implant-related failures.

Read more

Is there a difference in gait function of women treated with a ceramic resurfacing compared to women who received a conventional THA?

According, to a recent study published by Prof. Justin Cobb and his group, the answer is YES!

Read more

PEEK-on-ZTA ceramic Total Disc Replacement

PEEK-on-ZTA ceramic Total Disc Replacement has an acceptable safety profile with a success rate significantly greater than in the fusion control group: 93% vs 73.6% (P< .01).

Read more